---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-045668"
form_type: "8-K"
ticker: "ACOG"
cik: "0001655923"
company_name: "Alpha Cognition Inc."
filed_at: "2026-04-20T23:59:59+00:00"
generated_at: "2026-05-15T05:20:08.040767+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Alpha Cognition appoints Bethany Sensenig to board of directors

## Summary
- Bethany Sensenig appointed director on April 15, 2026; previously CFO/Head of Ops at Radius Health.
- Sensenig also serves on boards of Supernus Pharmaceuticals (SUPN) and KalVista Pharmaceuticals (KALV).
- Received initial grant of 5,489 RSUs and 6,991 stock options (exercise price $6.65), vesting one year from grant.
- Sensenig spent 13 years at Biogen in senior finance roles with P&L accountability for over $1B annual revenue.
- Compensated per company's non-employee director compensation policy; no arrangements or family relationships.

## SEC filing metadata
- accession: 0001213900-26-045668
- form_type: 8-K
- ticker: ACOG
- cik: 0001655923
- company_name: Alpha Cognition Inc.
- filed_at: 2026-04-20T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1655923/000121390026045668/0001213900-26-045668-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1655923/000121390026045668/ea028707001-8k_alphacog.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-045668
- JSON: https://secwatch.observer/filing/0001213900-26-045668.json
- Plain text: https://secwatch.observer/filing/0001213900-26-045668.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.